EOLS vs RCL · rev $157.2M vs P/E 26, rev $9.28B
Evolus Inc (EOLS) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported EOLS revenue for 2026-06-30 was $157.2M. Net income was -$18.7M. EOLS currently screens at market cap $597.0M.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
EOLS currently screens at market cap $597.0M. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the EOLS and RCL stock pages for the full models.
Not investment advice.